Marine Carotenoid Fucoxanthin as a Promising Anticancer Therapeutic Against Triple-Negative Breast Cancer (TNBC)

被引:0
|
作者
Ahmed, Shade [1 ]
Mendonca, Patricia [1 ]
Messeha, Samia S. [1 ]
Soliman, Karam F. [2 ]
机构
[1] Florida A&M Univ, Tallahassee, FL USA
[2] Florida A&M Univ, Coll Pharm, Tallahassee, FL USA
关键词
D O I
10.1124/jpet.122.176370
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
322
引用
收藏
页数:1
相关论文
共 50 条
  • [31] The outcome of special histologic types of triple-negative breast cancer (TNBC).
    Pogoda, Katarzyna
    Niwinska, Anna
    Murawska, Magdalena
    Olszewski, Wojciech
    Nowecki, Zbigniew
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Meeting the educational needs of women with triple-negative breast cancer (TNBC).
    Swiger, Kathleen Dickerson
    Sendecki, Jocelyn A.
    Guglielmino, Janine E.
    Rugo, Hope S.
    Domchek, Susan M.
    Anders, Carey K.
    Stricker, Carrie Tompkins
    Nelson, Hillary C. M.
    Hanson, Arin Ahlum
    Dinerman, Hayley
    Henry, Catherine Creme
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
    Lee, Jieun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [34] Discovery of a small molecule inhibitor for triple-negative breast cancer (TNBC)
    Saran, Uttara
    Chandrasekaran, Balaji
    Tyagi, Ashish
    Singh, Amandeep
    Ankem, Murali K.
    Sharma, Arun K.
    Damodaran, Chendil
    CANCER RESEARCH, 2022, 82 (12)
  • [35] Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review
    Tajbakhsh, Amir
    Rivandi, Mandi
    Abedini, Soheila
    Pasdar, Alireza
    Sahebkar, Amirhossein
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 140 : 17 - 27
  • [36] RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer
    My-my Huynh
    Jayanthan, Aarthi
    Pambid, Mary Rose
    Los, Gerrit
    Dunn, Sandra E.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (01) : 1 - 5
  • [37] Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy
    Dheeraj, Arpit
    Marques, Fernando Jose Garcia
    Tailor, Dhanir
    Bermudez, Abel
    Resendez, Angel
    Pandrala, Mallesh
    Grau, Benedikt
    Kumar, Praveen
    Haley, Carrsyn B.
    Honkala, Alexander
    Kujur, Praveen
    Jeffrey, Stefanie S.
    Pitteri, Sharon
    V. Malhotra, Sanjay
    CELL REPORTS MEDICINE, 2024, 5 (05)
  • [38] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Cho, Eun Yoon
    Chang, Myung Hee
    Choi, Yoon La
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 753 - 761
  • [39] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Eun Yoon Cho
    Myung Hee Chang
    Yoon La Choi
    Jeong Eon Lee
    Seok Jin Nam
    Jung-Hyun Yang
    Yeon Hee Park
    Jin Seok Ahn
    Young-Hyuck Im
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 753 - 761
  • [40] Inducing cell state transitions in triple-negative breast cancer (TNBC).
    Loo, Ser Yue
    Toh, Liping
    Pathak, Elina
    Tan, Wilson
    Ma, Siming
    Yuan, Ju
    Periyasamy, Giridharan
    Torta, Federico
    Chan, Jack
    Tan, Tira
    Sim, Yi Rong
    Tan, Veronique
    Tan, Benita
    Madhukumar, Preetha
    Yong, Wei Sean
    Ong, Kong Wee
    Wong, Chow Yin
    Wenk, Markus R.
    Foo, Roger
    Yap, Yoon-Sim
    Lim, Elaine
    Tam, Wai Leong
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 73 - 73